A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...

Pizza, soup, chicken were top sources of sodium across racial, ethnic groups; top four sources were different for Asian Americans ...

The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy. (HealthDay News) — The U.S. Food and Drug Administration has approved the ...

Belimumab increases the complete renal response rate among patients with pure or mixed proliferative class 3 or 4 lupus nephritis (LN) treated with mycophenolate mofetil (MMF). Richard Furie, MD ...

As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

A randomized controlled trial tested the efficacy and safety of a silicone-covered metallic stent compared with a conventional polymeric double-J stent in patients with malignant ureteral obstruction.

Inadequate response to ESAs is associated with a higher risk for major adverse cardiovascular events among patients receiving maintenance dialysis. Hyporesponsiveness to erythropoiesis-stimulating ...

The pledge comes as the United States plans to leave the international organization, The Washington Post reported.